Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation

Journal of Heart and Lung Transplantation

Volumn 33, Issue 1, 2014, Pages 88-93

  Sandner, Sigrid E ^a   Riebandt, Julia ^a   Haberl, Thomas ^a   Mahr, Stephane ^a   Rajek, Angela ^a   Schima, Heinrich ^a   Wieselthaler, George M ^b   Laufer, Guenther ^a   Zimpfer, Daniel ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti coagulation; Heart failure; Low molecular weight; Ventricular assist device

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 10A ANTIBODY; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN ISCHEMIA; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VENTRICULAR ASSIST DEVICE;

ANTI-COAGULATION; HEART FAILURE; LOW-MOLECULAR-WEIGHT; VENTRICULAR ASSIST DEVICE;

AGED; ANTICOAGULANTS; COHORT STUDIES; FEASIBILITY STUDIES; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84892169755     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2013.10.009     Document Type: Article

References (33)

1. F.X. Kleber, C. Witt, and G. Vogel et al. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease Am Heart J 145 2003 614 621
2. The Columbus Investigators Low-molecular-weight heparin in the treatment of patients with venous thromboembolism N Engl J Med 337 1997 657 662
3. M. Cohen, C. Demers, and E.P. Gurfinkel et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease N Engl J Med 337 1997 447 452
4. S.D. Berkowitz, S. Stinnett, and M. Cohen et al. Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction Am J Cardiol 88 2001 1230 1234
5. G. Montalescot, J.P. Collet, and M.L. Tanguy et al. Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin Circulation 110 2004 392 398
6. H. Jneid, J.L. Anderson, and R.S. Wright et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 126 2012 875 910
7. M.R. Jaff, M.S. McMurtry, and S.L. Archer et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association Circulation 123 2011 1788 1830
8. C. Stellbrink, U. Nixdorff, and T. Hofmann et al. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial Circulation 109 2004 997 1003
9. A.L. Klein, S.E. Jasper, and W.E. Katz et al. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study Eur Heart J 27 2006 2858 2865
10. G. Montalescot, V. Polle, and J.P. Collet et al. Low molecular weight heparin after mechanical heart valve replacement Circulation 101 2000 1083 1086
11. J. Fanikos, K. Tsilimingras, and N. Kucher et al. Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation Am J Cardiol 93 2004 247 250
12. P. Meurin, J.Y. Tabet, and H. Weber et al. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement Circulation 113 2006 564 569
13. L.W. Miller, F.D. Pagani, and S.D. Russell et al. Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
14. F.D. Pagani, L.W. Miller, and S.D. Russell et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J Am Coll Cardiol 54 2009 312 321
15. M.S. Slaughter, J.G. Rogers, and C.A. Milano et al. Advanced heart failure treaced with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
16. K.D. Aaronson, M.S. Slaughter, and L.W. Miller et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation Circulation 125 2012 3191 3200
17. M.S. Slaughter, Y. Naka, and R. John et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy J Heart Lung Transplant 29 2010 616 624
18. O. Ghez, R. Liesner, and A. Karimova et al. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on EXCOR ventricular assist device ASAIO J 52 2006 705 707
19. B. Meuris, J. Arnout, and D. Vlasselaers et al. Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants Artif Organs 31 2007 402 405
20. S.E. Sandner, D. Zimpfer, and P. Zrunek et al. Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation Artif Organs 32 2008 819 822
21. J.F. Canales, and J.J. Ferguson Low-molecular-weight heparins: mechanisms, trials, and role in contemporary interventional medicine Am J Cardiovasc Drugs 8 2008 15 25
22. J. Hirsh Low molecular weight heparin Thromb Haemost 70 1993 204 207
23. R.C. Becker, F.A. Spencer, and M. Gibson et al. Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes Am Heart J 143 2002 753 759
24. T.E. Warkentin, M.N. Levine, and J. Hirsh et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
25. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119(suppl):176S-93S
26. J.P. Collet, G. Montalescot, and E. Fine et al. Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trials J Am Coll Cardiol 41 2003 8 14
27. P.M. Eckman, and R. John Bleeding and thrombosis in patients with continuous-flow ventricular assist devices Circulation 125 2012 3038 3047
28. J. Suarez, C.B. Patel, and G.M. Felker et al. Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices Circ Heart Fail 4 2011 779 784
29. H. Tsukui, A. Abla, and J.J. Teuteberg et al. Cerebrovascular accidents in patients with a ventricular assist device J Thorac Cardiovasc Surg 134 2007 114 123
30. T.S. Kato, P.C. Schulze, and J. Yang et al. Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device J Heart Lung Transplant 31 2012 1 8
31. B.C. Sun, M.S. Firstenberg, and L.B. Louis et al. Placement of long-term implantable ventricular assist devices without the use of cardiopulmonary bypass J Heart Lung Transplant 27 2008 718 721
32. Z.T. Demirozu, R. Radovancevic, and L.F. Hochman et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device J Heart Lung Transplant 30 2011 849 853
33. J.A. Morgan, G. Paone, and H.W. Nemeh et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device J Heart Lung Transplant 31 2012 715 718